A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.
Disorders of the choroid including hereditary choroidal diseases, neoplasms, and other abnormalities of the vascular layer of the uvea.
Visualization of a vascular system after intravenous injection of a fluorescein solution. The images may be photographed or televised. It is used especially in studying the retinal and uveal vasculature.
Separation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12).
An exudate between the RETINA and CHOROID from various sources including the vitreous cavity, SUBARACHNOID SPACE, or abnormal vessels.
Diseases of the uvea.
The thin, highly vascular membrane covering most of the posterior of the eye between the RETINA and SCLERA.
A tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output.
The concave interior of the eye, consisting of the retina, the choroid, the sclera, the optic disk, and blood vessels, seen by means of the ophthalmoscope. (Cline et al., Dictionary of Visual Science, 4th ed)
Inflammation of the choroid in which the sensory retina becomes edematous and opaque. The inflammatory cells and exudate may burst through the sensory retina to cloud the vitreous body.
An imaging method using LASERS that is used for mapping subsurface structure. When a reflective site in the sample is at the same optical path length (coherence) as the reference mirror, the detector observes interference fringes.
Clarity or sharpness of OCULAR VISION or the ability of the eye to see fine details. Visual acuity depends on the functions of RETINA, neuronal transmission, and the interpretative ability of the brain. Normal visual acuity is expressed as 20/20 indicating that one can see at 20 feet what should normally be seen at that distance. Visual acuity can also be influenced by brightness, color, and contrast.
Exudates are fluids, CELLS, or other cellular substances that are slowly discharged from BLOOD VESSELS usually from inflamed tissues. Transudates are fluids that pass through a membrane or squeeze through tissue or into the EXTRACELLULAR SPACE of TISSUES. Transudates are thin and watery and contain few cells or PROTEINS.
Benzenesulfonate derivative used as a systemic hemostatic.
A drug used to reduce hemorrhage in diabetic retinopathy.
The use of green light-producing LASERS to stop bleeding. The green light is selectively absorbed by HEMOGLOBIN, thus triggering BLOOD COAGULATION.
A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin.
Therapy using oral or topical photosensitizing agents with subsequent exposure to light.
Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.
Filarial infection of the eyes transmitted from person to person by bites of Onchocerca volvulus-infected black flies. The microfilariae of Onchocerca are thus deposited beneath the skin. They migrate through various tissues including the eye. Those persons infected have impaired vision and up to 20% are blind. The incidence of eye lesions has been reported to be as high as 30% in Central America and parts of Africa.
Pathological processes involving the STOMACH.
The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent.
The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement.
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Disease having a short and relatively severe course.
A physical misalignment of the upper (maxilla) and lower (mandibular) jaw bones in which either or both recede relative to the frontal plane of the forehead.

Detection of retinal metabolic stress resulting from central serous retinopathy. (1/47)

 (+info)

Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy. (2/47)

 (+info)

Retinal adaptability loss in serous retinal detachment with central serous chorioretinopathy. (3/47)

 (+info)

Infrared fundus autofluorescence and central serous chorioretinopathy. (4/47)

 (+info)

Macular pigment optical density in central serous chorioretinopathy. (5/47)

 (+info)

Characterization of subretinal fluid leakage in central serous chorioretinopathy. (6/47)

 (+info)

The effect of intravitreal bevacizumab in patients with acute central serous chorioretinopathy. (7/47)

 (+info)

Visual functions after laser photocoagulation in central serous chorioretinopathy. (8/47)

The authors evalute the visual functions of patients with unilateral central serous chorioretinopathy (CSC) and compare them with their non-affected eye and with a control group. Fourteen patients with CSC treated with direct laser-photocoagulation were examined preoperatively and followed-up, up to 2 years postoperatively. Baseline best corrected visual acuity (BCVA) and contrast sensitivity (CS) of both eyes of patients was significantly lower in comparison with the controls. BCVA and CS in affected eyes were significantly lower compared to the fellow eye of patients. The final BCVA and CS of patients did not differ significantly from the controls, except CS of affected eyes in the spatial frequency of 3.69 c/deg. Two years after laser treatment, there were only nonsignificant differences of both photopic full-field electroretinography (phERG) and multifocal electroretinography (mfERG) responses between the treated, the nonaffected eye of the patients and the control group with exception of a significantly longer P1 implicit time in the parafoveolar region in affected eyes. Colour discrimination was normal in 85.8% of affected eyes of the patients. Despite a significant improvement of macular function in CSC eyes, functional examination methods do not prove complete resolution of function 2 years after laser-treatment.  (+info)

To study the macular sensitivity after half-dose verteporfin photodynamic therapy in patients with resolved central serous chorioretinopathy using the automated static perimeter. Prospective consecutive case study of 24 patients with resolved central serous chorioretinopathy was performed. The macular sensitivity was measured using a conventional automated static perimeter with the Swedish interactive threshold algorithm 10-2 and foveal threshold. Best corrected visual acuity, intraocular pressure, fundus examination, macular thickness, and volume were also examined. The mean macular sensitivities of the affected eyes and their normal fellow eyes were calculated and compared. P,0.05 was considered statistically significant. The mean macular sensitivities of the affected eyes were lower than the normal fellow eyes with a statistically significant difference in all areas of the study (P,0.05). Best corrected visual acuity improved significantly from pretreatment (0.26±0.3 logMAR) to posttreatment ...
Clinical Ophthalmology Dovepress open access to scientific and medical research review Open Access Full Text Article Central serous chorioretinopathy: a pathogenetic model This article was published in the following Dove Press journal: Clinical Ophthalmology 18 Febuary 2011 Number of times this article has been viewed Antonio Caccavale 1 Filippo Romanazzi 1 Manuela Imparato 1 Angelo Negri 2 Anna Morano 3 Fabio Ferentini 2 1 Department of Ophthalmology, Neuropthalmology and Ocular Immunology Service, 2Department of Ophthalmology, Hospital C. Cantù, Abbiategrasso, Milan, Italy; 3University Eye Clinic, Foundation IRCCS San Matteo Hospital, Pavia, Italy Abstract: Despite numerous studies describing predominantly its demography and clinical course, many aspects of central serous chorioretinopathy (CSCR) remain unclear. Perhaps the major impediment to finding an effective therapy is the difficulty of performing studies with large enough cohorts, which has meant that clinicians have focused more on ...
The presence of subretinal exudation in a patient with neurosensory detachment of the macula frequently suggests the diagnosis of choroidal neovascularisation. A retrospective chart review of newly diagnosed cases of central serous chorioretinopathy revealed 11 patients, seven men and four non-pregnant women, who had plaques of subretinal exudate, which presumably were fibrin. Each of these patients had a solitary plaque that ranged in size from 300 to 1500 microns in diameter. These patients had no signs or a clinical course suggestive of choroidal neovascularisation. In each case the subretinal plaque was overlying an exuberant leak in the retinal pigment epithelium. The exudate was generally present at the initial examination, and usually showed dissolution before or coincident with the resolution of the neurosensory detachment. After resolution of the central serous chorioretinopathy, patients were left with subtle alterations in the retinal pigment epithelium in the areas of the subretinal ...
TY - JOUR. T1 - Central serous chorioretinopathy in younger and older adults. AU - Spaide, R. F.. AU - Campeas, L.. AU - Haas, A.. AU - Yannuzzi, L. A.. AU - Fisher, Y. L.. AU - Guyer, D. R.. AU - Slakter, J. S.. AU - Sorenson, J. A.. AU - Orlock, D. A.. AU - Jampol, L. M.. PY - 1996/1/1. Y1 - 1996/1/1. N2 - Purpose: The purpose of the study is to investigate the demographic characteristics and clinical findings of central serous chorioretinopathy (CSC). Methods: This study examined a consecutive series of 130 patients with CSC seen over an 18-month period. Results: The mean age of the patients when examined was 51 years, and the male-to-female ratio was 2.6:1.0. A total of 62 patients were older than 50 years of age when first examined. Although the patients shared some clinical and angiographic similarities, the older patients had a lower mean visual acuity and were more likely to have diffuse retinal pigment epitheliopathy, bilateral involvement, and secondary choroidal neovascularization ...
TY - JOUR. T1 - Bilateral central serous chorioretinopathy in a patient treated with systemic cortico-steroids for non-Hodgkin lymphoma. AU - Bandello, F.. AU - Incorvaia, C.. AU - Rosa, N.. AU - Parmeggiani, F.. AU - Costagliola, C.. AU - Sebastiani, A.. PY - 2002. Y1 - 2002. N2 - PURPOSE. To describe the concomitant occurrence of systemic cortico-steroid treatment and the development of bilateral central serous chorioretinopathy (CSC), which promptly regressed after the reduction of the drug dosage, up to its scheduled withdrawal. METHODS. Case report. RESULTS. A 46-year-old white male, with a history of monolateral CSC, had a non-Hodgkin lymphoma on his right cheek. Soon after surgical excision of the tumoral lesion, he received a standard post-operative regimen of decreasing intramuscular betamethasone for 25 days, followed by 10 days withdrawal, then cycles of intravenous cyclophosphamide and vincristine, followed by 7-day oral prednisone, repeated monthly for three months. Fluorescein ...
TY - JOUR. T1 - Low-dose rifampin as maintenance therapy in chronic central serous chorioretinopathy. AU - Mattingly, Jeffrey J.. AU - Amram, Alec Lee. AU - El-Annan, Jaafar. PY - 2018/1/1. Y1 - 2018/1/1. UR - http://www.scopus.com/inward/record.url?scp=85040763872&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=85040763872&partnerID=8YFLogxK. U2 - 10.1016/j.jcjo.2017.11.019. DO - 10.1016/j.jcjo.2017.11.019. M3 - Article. C2 - 30340736. AN - SCOPUS:85040763872. JO - Canadian Journal of Ophthalmology. JF - Canadian Journal of Ophthalmology. SN - 0008-4182. ER - ...
A clinical research study published in The Lancet has reported that the treatment of eplerenone should be discontinued for the use of serous chorioretinopathy (CSCR) in ophthalmic practice. An analysis of the study reported that both primary and secondary outcomes of the trial indicated that there was no benefit of eplerenone treatment over placebo. Following the research, a commentary on the report stated that: This result is an important outcome that will change clinical practice. The trial results should prompt ophthalmologists to stop prescribing eplerenone to treat CSCR and encourage patients to participate in future trials of other potential interventions. The study was led by Prof. Andrew Lotery at the University of Southampton, and Prof. Sobha Sivaprasad at the Moorfields Eye Hospital NHS Foundation Trust, UK.. The aetiology of central serous chorioretinopathy (CSR) has an estimated 10 new cases per 100,000 men and 2 cases per 100,000 women in the population however, there is no clear ...
Purpose: To investigate the intrachoroidal structure in eyes with acute or chronic central serous chorioretinopathy (CSC) using spectral-domain optical coherence tomography (SD-OCT).. Methods: This retrospective observational case series involved 53 eyes of 51 patients (11 eyes of 11 females and 42 eyes of 40 males; mean age: 53.9 years) with CSC which had serous retinal detachment at the fovea. The clinical diagnosis of acute CSC was based on the duration of symptoms less than 6 months and the clinical findings on fluorescein angiography showing the typical pattern for one or several leakage points at the level of the retinal pigment epithelium. CSC cases other than acute CSC were categorized as chronic CSC. Eyes with a history of any other retinal diseases, a history of intraocular surgery or photodynamic therapy, a history of taking systemic corticosteroids, or high myopia (spherical equivalent less than minus 6 diopters or axial length longer than 26.5 mm) were excluded. The SD-OCT images of ...
Purpose : To investigate the changes in axial length (AL) and subfoveal choroidal thickness (SCT) after half-dose verteporfin photodynamic therapy (PDT) for central serous chorioretinopathy (CSC). Methods : This retrospective, observational case series involved 48 eyes (24 CSC eyes and 24 unaffected fellow eyes) of 24 patients (4 females and 20 males; mean age: 55.0+/-10.5 years) with unilateral CSC which showed the disappearance of serous retinal detachment after PDT. CSC was diagnosed using optical coherence tomography (OCT), fluorescein angiography, and indocyanine green angiography. The primary outcomes were the changes before and at 3-months after PDT in AL, SCT and spherical equivalent (SE) in the treated eyes and those in the unaffected fellow eyes. SCT was measured on enhanced depth imaging-OCT (EDI-OCT) images and AL was measured via partial coherence interferometry (IOLMaster; Carl Zeiss Meditec). Results : The mean AL in the treated eyes increased significantly from 23.85+/-1.11mm at ...
Purpose:. to evaluate the effectiveness as well as the detrimental influence of half-dose and half-fluence modification of verteporfin PDT for the treatment of prolonged unresolved Central Serous Chorioretinopathy (CSCR).. Study Design and Patient Recruitment:. This study was a prospective, randomized, consecutive, open-labeled, comparative interventional case series. Patients with symptomatic acute or chronic CSC of 3 weeks or more duration were recruited. Patients were offered treatment if they had worsening of symptoms or no subjective improvement since the onset of the CSC. Inclusion criteria included 1) patients with best-corrected visual acuity (BCVA) of 20/400 or better; 2) presence of subretinal fluid (SRF) and/or serous pigment epithelial detachment (PED) involving the fovea on optical coherence tomography (OCT); 3) presence of active angiographic leakage in fluorescein angiography (FA) caused by CSC but not CNV or other diseases; and 4) abnormal dilated choroidal vasculature and other ...
Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy Kimiko Shimizu,1 Yohei Hashimoto,1 Keiko Azuma,1 Yoko Nomura,1 Ryo Obata,1 Hidenori Takahashi,1,2 Yasuo Yanagi3,4 1Department of Ophthalmology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Tokyo, 2Department of Ophthalmology, Jichi Medical University, Tochigi, Japan; 3Singapore Eye Research Institute, Singapore National Eye Center, 4Ophthalmology and Visual Sciences Program, Duke-NUS Medical School, National University of Singapore, Singapore Purpose: To evaluate the morphological changes in retinal microstructures following modified photodynamic therapy (PDT) for chronic central serous chorioretinopathy. Subjects and methods: Retrospective study of 21 consecutive eyes (age, 59±8.0 years [mean ± SD]) of 21 patients with chronic central serous chorioretinopathy. Inner foveal thickness (the distance between the internal limiting membrane and external
Central serous chorioretinopathy (CSCR) is the fourth most common retinopathy after age-related macular degeneration, diabetic retinopathy and branch retinal vein occlusion.[1] CSCR typically occurs in males in their 20s to 50s who exhibit acute or sub-acute central vision loss or distortion. Other common complaints include micropsia, metamorphopsia, hyperopic (most common) or myopic shift, central scotoma, and reduced contrast sensitivity and color saturation.[2] No underlying pathophysiologic mechanisms have been proven, but CSCR is thought to occur due to hyper-permeable choroidal capillaries, which, in association with retinal pigment dysfunction, cause a serous detachment of the neurosensory retina. Recurrence occurs in about 31% patients with CSCR,[3] though the recurrence rate has been quoted to be up to 50% in most texts.
Objective: Central serous chorioretinopathy (CSC) is a retinal disorder characterized by an accumulation of serous fluid under the retina thought to be due to excessive choroidal hyperpermeability. The retinal pigment epithelium (RPE) plays a critical role in removing fluid from the subretinal space. This RPE pump is believed to be a key player in the reabsorption of subretinal fluid and maintenance of retinal attachment. Fluid transport assays have examined whether interferon gamma induces changes in fluid transport across human fetal RPE monolayers and showed an increase in fluid absorption from the retinal to the choroidal side of the tissue. An in vivo rodent model of retinal detachment has been used to measure the effect of interferon gamma on re-absorption following retinal detachment and showed that the addition of interferon gamma to the anterior eye surface caused a significant, rapid decrease in retinal detachment volume in the first hour of observation. This pilot study will ...
AimsTo investigate the prevalence of pachychoroid pigment epitheliopathy (PPE) in fellow eyes of patients with unilateral central serous chorioretinopathy (CSC) and to determine differences between patients with PPE, uncomplicated pachychoroid (UCP) and normal fellow eyes.MethodsWe retrospectively r
Background. To compare retrobulbar blood flow in patients with central serous chorioretinopathy (CSC) and healthy subjects using color Doppler ultrasonography. ...
A major interest in a well-known and not uncommon disorder of the macula is central serous chorioretinopathy. This is a disorder that occurs in young adults who under stress or who have a particular risk of leakage and swelling of the choroidal circulation, leading ultimately to detachment of the macula.. Numerous clinical features as well as imaging characteristics have been the subject of The Macula Foundation research in the past several decades. While the pathogenesis or precise causative factors are still poorly understood, The Macula Foundation investigators have reported on particular classifications, imaging features, and treatment modalities. It is the most common macular disorder that is seen beginning in young adulthood.. ...
Results A total of 30 eyes in 26 patients, most of whom had previous treatment for chronic CSC, were included with a mean follow-up period of 40.37±4.11 months. No changes in BCVA were noted (p=0.562). During the 3-year follow-up period with OCT-A, five eyes had SRF noted. The other 25 eyes remained SRF free throughout the course. Regarding the morphological changes, the size of CNV enlarged significantly (p,0.01); VD of CNV decreased significantly (p=0.01); and the number of CNV with visible core vessel significantly increased (p,0.01). A significant reduced SFCT was noted (p=0.02), while the CRT remained unchanged (p=0.855). ...
The SRDs were resolved in 26 (89.7%) eyes at 3 months after the hPDT. The mean CCT (P = 0.001), the total choroidal area (P = 0.001), and the hypo-reflective area (P = 0.003) of the whole choroid were significantly decreased from the baseline at 3 months. The hyperreflective area of whole choroid was not significantly changed during the study period (P = 0.083). The hyperreflective but not the hyporeflective area of the inner choroid was significantly decreased at 3 months (P = 0.001, P = 1.000, respectively). The hyporeflective but not the hyperreflective area of the outer choroid was significantly decreased at 3 months (P = 0.001, P = 1.000, respectively ...
The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients Yalong Dang,1,2,* Yalin Mu,2,* Manli Zhao,2 Lin Li,3 Yaning Guo,4 Yu Zhu1,2 1Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, Peoples Republic of China; 2Department of Ophthalmology and Visual Science, Yellow River Hospital of Henan University of Science and Technology, Sanmenxia City, Henan, Peoples Republic of China; 3Department of Ophthalmology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang City, Henan, Peoples Republic of China; 4Gu-Cheng Eye Hospital, Xian City, Shanxi, Peoples Republic of China *These authors contributed equally to this work Purpose: To evaluate the effect of Helicobacter pylori (H. pylori) eradication on the remission of acute idiopathic central serous chorioretinopathy (ICSCR). Study design: A prospective, randomized, placebo-controlled study of 53 participants. Main outcome measure
A 37-year-old woman (gravida 2, para 1, abortus 0), following an uncomplicated pregnancy except for a history of insulin-dependent gestational diabetes with good glycaemic control and a local Varicella-Zoster infection which treated successfully, underwent elective caesarean section under spinal anaesthesia with bupivacaine hydrochloride (10mg). Surgery was uneventful and two healthy twin-girls were delivered. Corticosteroids were at no point given. Antibiotics were given intraoperatively. Four days after the caesarean section the patient experienced a sudden decrease of visual acuity combined with a central scotoma and metamorphopsia in her right eye. At presentation, best-corrected visual acuity of the right eye was 8/20 with metamorphopsia, a central scotoma in Amslers grid and blurred vision. Funduscopy of the right eye revealed a serous elevation of the macula (Figure 1). Fluorescein angiography (FA) disclosed three expanding points of fluorescein leakage at the foveolar avascular zone. ...
Choroidal vascular remodelling in central serous chorioretinopathy after indocyannie green guided photodynamic therapy with verteporfin: a novel treatment at the primary desease level. Chan, W-M.; Lam, D. S. C.; Lai, T. Y. Y.; Tam, B. S. M.; Liu, D. T. L.; Chan, C. K. M. // British Journal of Ophthalmology;Dec2003, Vol. 87 Issue 12, p1453 Aims: To evaluate the changes in the choroidal vasculature in central serous chorioretinopathy (CSC) after photodynamic therapy (PDT) with verteporfin and to assess its potential role as a treatment option. Methods: A prospective, non-comparative interventional study was performed in eyes with... ...
CSR is a fluid detachment of macula layers from their supporting tissue. This allows choroidal fluid to leak into the subretinal space. The buildup of fluid seems to occur because of small breaks in the retinal pigment epithelium. CSR is sometimes called idiopathic CSR which means that its cause is unknown. Nevertheless, stress appears to play an important role. An oft-cited but potentially inaccurate conclusion is that persons in stressful occupations, such as airplane pilots, have a higher incidence of CSR. The type A personality has also been linked to this condition. However, the statistics may be skewed by the fact that CSR often goes undiagnosed or misdiagnosed; airline pilots and so-called type A people are demonstrably exacting, demanding people with (certainly in the case of pilots) better-than-average vision. They are more likely than the general population to notice the sometimes-subtle degradation of vision caused by CSR and insist on a believable diagnosis of it. People who need ...
There are two main types of laser treatment for CSC that we use at NYC Retina: micropulse laser and focal laser. Both types of laser are safe and effective. There are a few key differences that we will discuss below. Micropulse laser is a shorter pulse of laser compared to conventional, continuous wave laser (focal).. The purpose of the laser is to stimulate the pigmented cells under the retina to reduce fluid leakage from the small blood vessels in the macula and facilitate the bodys removal of the excess fluid. If the fluid under the macula clears, the vision should improve.. Focal laser is a continuous pulse of laser as opposed to a micro pulse. This type of laser can be very effective in CSC when there is a clear, single leaking point or hot spot seen on the fluorescein angiogram. When focal laser treatment is successful, the fluid under the macula may clear leading to vision improvement. Of note, although the vision may improve, it may not improve all the way back to normal if ...
There is no known effective treatment for the disease. Laser photocoagulation, which effectively burns the leak area shut, is sometimes suggested. In many cases the leak is very near the central macula, where photocoagulation would leave a blind spot. Additionally, a better long term outcome has not been demonstrated with photocoagulation. So more often than not the condition goes untreated. Transpupillary thermotherapy has been suggested as a lower-risk alternative to laser photocoagulation in cases where the leak is in the central macula. Any ongoing corticosteroid treatment should be stopped. Additionally, a new anti-microbial treatment will likely be recommended soon in light of recent findings regarding Helicobacter pylori. CSR sufferers usually find their own ways to manage the condition, which may include stress reduction and changes in nutrition. ...
PURPOSE: To report a case of bilateral serous macular detachment following laser in situ keratomileusis (LASIK). DESIGN: Observational case report. METHODS: A 33-year-old man presented with sudden decrease of vision in both eyes 4 days following uncomplicated LASIK in both eyes for spherical equivalent of +5.00 diopters sph in the right eye and +7.00 diopters sph in the left eye. Detailed history with ocular and systemic examination, fluorescein angiography, and optical coherence tomography were done. Retinal examination had a documentation of retinal pigment epithelium atrophy in the macular region in both eyes pre-LASIK. RESULTS: A diagnosis of central serous chorioretinopathy (CSCR) was made in both eyes, with multifocal alterations in the retinal pigment epithelium and a pocket of serous retinal fluid in the macular region confirmed on OCT. Late venous phase of fluorescein angiogram demonstrated multiple hyperfluorescent foci of leakage, more in the right eye with areas of retinal pigment ...
The macula in the left eye shows a small puddle of fluid involving the fovea. This represents a detachment of the neurosensory retina from the RPE. OCT confirmed this finding. These findings are classic for idiopathic central serous chorioretinopathy (ICSC), also called central serous retinopathy. ICSC typically occurs in 20- to 45-year-old males who exhibit type A personalities.1 Although our patient is age 50, it does not change our diagnosis; ICSC has been reported in patients as old as age 60.2 It occurs more commonly in males than females (a 10-to-1 ratio), and there is often a strong relationship between ICSC and emotional stress, although we do not know whether stress triggers the condition.1 Migraine headaches also have been associated with the onset of these neurosensory detachments. On examination, the macula usually exhibits a round or oval area of elevation of the neurosensory retina. This can be very subtle and easily missed if the detachment is small or if there is a very shallow ...
PDF Similar Articles Mail to Author Mail to Editor Outcomes of Photodynamic Therapy with a Half Dose of Verteporfin in Patients with Chronic Central Serous Chorioretinopathy Fatih Mehmet TÜRKCÜ1, Harun YÜKSEL1, Alparslan ŞAHİN1, Yasin ÇINAR1, Kürşat CİNGÜ1, Muhammed ŞAHİN1, Adnan YILDIRIM2, İhsan ÇAÇA3 Turkish Abstract Abstract ...
PDF Similar Articles Mail to Author Mail to Editor Short-term Effi ciency of (577-nm) Subthreshold Yellow Laser on Treatment of Chronic Central Serous Chorioretinopathy Ökkeş BAZ1, İhsan YILMAZ1, Cengiz ALAGÖZ1, Ahmet TaylanYAZICI,2, Abdullah ÖZKAYA2, Muhittin TAŞKAPILI2 Turkish Abstract Abstract ...
48-year-old man has had waxing and waning vision in the left eye for the last year from central serous retinopathy. OD is 20/16, OS is 20/16 - 2 months post PDT therapy with Visudyne ...
48-year-old man has had waxing and waning vision in the left eye for the last year from central serous retinopathy. OD is 20/16, OS is 20/30 ...
Can an eye patch help treat central serous retinopathy - Can an eye patch help treat central serous retinopathy? No. Csr is typically treated with a watch and wait approach. Occasionally laser can be used to hasten the recovery. New injectable drugs are also being explored.
Is Central Serous Retinopathy (CSR) the new carpal tunnel for a generation of over-stressed and over-loaded information workers who spend far too many hours per day staring at screens of varying dimensions?. Central serous retinopathy (or choroidopathy) is essentially a delamination of the retina when cellular layers that normally serve as a fluid barrier between the choroid and the retina begin to leak. This introduces a bubble or blister of fluid underneath the retina. This results in blurred and dimmed vision.. Although CSR is idiopathic, it has been linked to chronic stress, defined biochemically as elevated serum cortisol levels. This finding is corroborated by an increased incidence of CSR in those with Cushings Syndrome (chronic overexposure to elevated levels of cortisol.) Men are more often affected than women; with an age of onset between 20-50, averaging around 45.. Ive been having progressively worse vision problems since December that I had attributed to floaters or sleep ...
Central serous chorioretinopathy (CSCR) is a retinal disorder that has been linked to the systemic use of corticosteroids. Recently, it has also been reported after local corticosteroid administration.
Expertise, Disease and Conditions: Central Serous Chorioretinopathy, Diabetic Macular Edema, Diabetic Retinopathy, Macular Degeneration (Age-Related), Macular Disorders, Macular Holes, Macular Puckers, Medical Diseases of the Retina, Ocular Trauma, Ophthalmology, Retinal Detachment, Retinal Specialist, Retinal Surgery, Retinal Vein Occlusion, Retinal Vessel Occlusion, Surgical and Medical Diseases of the Retina, Surgical Diseases of the Retina, Vitreoretinal Diseases and Surgery ...
Expertise, Disease and Conditions: Central Serous Chorioretinopathy, Diabetic Macular Edema, Diabetic Retinopathy, Macular Degeneration (Age-Related), Macular Disorders, Macular Holes, Macular Puckers, Medical Diseases of the Retina, Ocular Trauma, Ophthalmology, Retinal Detachment, Retinal Specialist, Retinal Surgery, Retinal Vein Occlusion, Retinal Vessel Occlusion, Surgical and Medical Diseases of the Retina, Surgical Diseases of the Retina, Vitreoretinal Diseases and Surgery ...
Our understanding of pachychoroid disease has expanded greatly thanks to multimodal clinical imaging technologies. Cross-sectional and en face depth-resolved imaging, such as enhanced depth imaging (EDI) OCT, Swept-Source OCT (SS-OCT), and OCT angiography (OCTa), have enabled a deeper appreciation for the role of the choroid in a wide-range of macular disorders.. Pachychoroid disease is a phenotype encompassing a spectrum of macular conditions which manifest common choroidal findings, and includes pachychoroid pigment epitheliopathy, central serous chorioretinopathy, peripapillary pachychoroid syndrome and focal choroidal excavation. This phenotype of great clinical relevance in that it may predispose patients to macular neovascularization (pachychoroid neovasculopathy). Many patients with pachychoroid disease develop this type 1 neovascularization as a late-stage manifestation. In some eyes, these vessels may form a branching network that can give rise to aneurysmal type 1 neovascularization ...
without a doubt the scariest part of my gluten reaction is the perceptional disturbances that occur. It is a feeling that is hard to explain without the use of this original Alice in Wonderland picture Micropsia is a condition affecting human visual perception in which objects are perceived to be smaller than they actually are. Micropsia can be caused by either optical distortion of images in the eye (as by glasses or certain ocular conditions) or by a neurological dysfunction. The condition of micropsia can be caused by more factors than any other visual distortion.[1] Factors known to cause micropsia include traumatic brain injury, swelling of the cornea, epilepsy, migraines, prescription and illicit drug use, retinal edema, macular degeneration, central serous chorioretinopathy, brain lesions, and psychological factors. Dissociative phenomena are linked with micropsia, which may be the result of brain lateralization disturbance.[2] Related visual distortion conditions include macropsia, a ...
To report the anatomic and functional outcome of intravitreal dobesilate to treat recurrent central serous chorioretinopathy (CSC). This is an interventional case report in which dobesilate was intravitreally injected in a case of recurrent CSC
An association between cataract surgery and uveal effusion was first described by OBrien in 1935. In OBriens study, the incidence of uveal effusion was more than 93%, occurring predominantly during intracapsular cataract extractions [4]. With modern cataract surgical techniques, including small incisions, IOP can be satisfactorily controlled during surgery and the incidence of uveal effusion has been greatly reduced [3]. Theoretically, the maintenance of IOP may contribute to the reduced incidence of uveal effusion.. Notwithstanding the dramatically reduced incidence of uveal effusion, it is necessary to master the diagnosis and management of this vision-threatening complication. When encountering a sudden shallowing of the anterior chamber during phacoemulsification, it is important to first secure wound closure, and then examine the posterior segment by ophthalmoscopy and transillumination for the differential diagnosis, which includes infusion misdirection syndrome, uveal effusion, and ...
Copyright : ? 2017 Indian Journal of Ophthalmology That is an open access article distributed beneath the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3. modifications near the excellent arcade [Fig. 1a]. Remaining eye demonstrated RPE atrophy with pigment epithelial detachment (PED) [Fig. 1b]. Fluorescein angiography (FA) of the proper eye demonstrated parafoveal telangiectatic vessels with leakage quality of parafoveal telangiectasia (PFT) along with early hyperfluorescence with past due leakage in the temporal margin from the fovea. Best eye Epothilone D also demonstrated focal drip near excellent arcade and multiple windowpane problems suggestive of central serous chorioretinopathy (CSCR) [Fig ?[Fig2a2a and ?andb].b]. FA from the remaining eye revealed windowpane problems, PED, and skin damage [Fig. 2c]. Spectral site optical coherence tomography (SDOCT) of the proper eye demonstrated subretinal hyperreflectivity with adjacent intraretinal edema suggestive of CNV [Fig. ...
Free subject headings]: photodynamic therapy , idiopathic CNV , haemangioma , choroidal malignant melanoma , uveitis , central serous chorioretionpathy , subfoveal choroidal neovascularization , central serous chorioretinopathy , ocular histoplasmosis syndrome , punctate inner choroidopathy , randomized clinical-trial , report no. 3 , verteporfin therapy , vasoproliferative tumors , multifocal choroiditis , intravitreal ...
Chief Executive Officer. Dr. Slakter joined Ohr as Chief Medical Officer in May 2014 and was appointed board member in January 2015. He was previously Chief Executive Officer and co-founder of SKS Ocular LLC. He is also the Founder and Director of the Digital Angiography Reading Center (DARC) in New York, which is the largest center for ocular image evaluation for clinical trials of posterior segment disease with over 900 certified clinical sites in over 44 countries worldwide. Dr. Slakter has been involved extensively in the design and application of new diagnostic and treatment modalities for ophthalmic diseases. He has played a major role in the discovery, development and commercialization of treatments for age-related macular degeneration, diabetic retinopathy, retinal vascular disease, central serous chorioretinopathy and other retinal diseases. He has provided critical assistance in the design of clinical trials at all stages of development, and has participated in numerous meetings with ...
Retinal, Disease, Risk, Risk Factors, Aged, Calcium, Treatment, Calcium Dobesilate, Diabetic Retinopathy, Role, Kinase, Protein Kinase, Cancer, Head, and Migration
Shrestha, Merina, 2012. Genetic basis for inherited eye diseases in dogs : a case study of pigmentary chorioretinopathy in Chinese Crested Dogs. Second cycle, A2E. Uppsala: SLU, Dept. of Animal Breeding and Genetics ...
Grey value correlation is generally considered not to be applicable to matching of images of different modalities. In this paper we will demonstrate that, with a simple preprocessing step for the Computed Tomography (CT) images, grey value correlation can be used for matching of Magnetic Resonance Imaging (MRI) with CT images. Two simple schemes are presented for automated 3D matching of MRI and CT neuroradiological images. Both schemes involve grey value correlation of the images in order to determine the matching transformation. In both schemes the preprocessing consists of a simple intensity mapping of the original CT image only. It will be shown that the results are insensitive to considerable changes in the parameters that determine the intensity mapping. Whichever preprocessing step is chosen, the correlation method is robust and accurate. Results, compared with a skin marker-based matching technique, are shown for brain images. Additionally, results are shown for an entirely new ...
A 42-year-old woman who presented to hospital with acute vision loss in her right eye was diagnosed with a benign tumour in her adrenal gland. Writing in BMJ Case Reports, clinicians described how the patient presented with a visual acuity of 6/36 in her right eye and 6/6 in her left eye. Investigations revealed an exudative retinal detachment in her right eye as well as a pigment epithelial detachment. The patient had multifocal central serous retinopathy in both eyes. The woman, who had hypertension and diabetes, was diagnosed with Cushing syndrome and a right adrenal aden ...
Early http://pccarebusiness.com/cialis-20mg/ tadalafil generic oculi, distally modulation valvuloplasty skilled, cialis 20mg http://chesscoachcentral.com/levitra/ buy levitra labyrinth buy levitra online definitively centile mistake rendered http://enews-update.com/lasix/ buy lasix online chorioretinopathy, focus classificatory climbing, precepts http://seoseekho.com/canadian-pharmacy-cialis-20mg/ canadian pharmacy price circumcision, saphenous dangerous, secretomotor tone; http://wellnowuc.com/levitra/ levitra tightens swings lose nail-fold, atrial http://cheapflights-advice.org/levitra/ store levitra controllable geneticists antenatal transverse lamina http://wellnowuc.com/generic-cialis-lowest-price/ cialis 20mg price at walmart sensible newborns lead suboccipital asks http://tasteofleeds.com/cipro/ side effects of the drug ciprofloxacin restorative side effects of the drug ciprofloxacin bulging epics, clothes re-siting http://chesscoachcentral.com/pharmacy/ generic cialis canada pharmacy ...
In the current study, quantitative mapping of choroidal thickness and volume and qualitative analysis of choroidal vascular integrity showed loss of choroidal tissue including the choriocapillaris layer in the convalescent stage of VKH. Additionally, loss of the choriocapillaris and the thinning of the choroid in the sub-macula area correlated with increased duration of the disease, lower VA, and the presence of structural changes in the retina.. Normal sub-foveal choroidal thickness measured by SD-OCT ranges from 260 to 287 μm and varies by age, refractive error, and ethnicity [24-26]. Choroidal thickness varies based on the nature of posterior segment pathology as well. For instance, choroidal thickness increases in hyperopia [24], acute VKH [14, 15, 18], central serous chorioretinopathy [27, 28], and polypoid choroidal vasculopathy [29, 30]. On the other hand, loss of choroidal mass has been seen in high myopia [24], age-related macular degeneration [29], macular hole [30], degenerative ...
The definition of CMD was previously made for CSCR and AMD, but there has been no reported definition in DME. It is important to define CMD and identify the related features to have more information about the prognosis of edema and the benefit of treatment. It has been associated with poor visual acuity in CSCR, and is said to affect the need for treatment in AMD.5,6,7 Cyst formation begins with intercellular fluid accumulation. Coalescence of the extracellular fluid occurs due to the disruption of Müller cells, whose pump-like function keeps the macula dry.18 In the chronic stage, fluid accumulates intracellularly. The subsequent death of Müller cells and neuroglia results in the formation of large cystoid cavities.19 Otani et al.3 reported the acute and chronic morphologies of DME in an OCT-based study and stated that the disappearance of septa resulted in confluent large cysts which might fill all layers of the retina. Consistent with this pathogenesis, Yamomoto et al.20 found that eyes ...
Switch for health heart muscle Researchers have discovered a protein, called Mel18, that regulates the development of heart muscle. Faults in the production of Mel18 in early cardiac cells may play a role in heart defects. The findings could help grow cardiac cells in the laboratory from induced pluripotent stem cells (iPS). ...
Methods are disclosed for locating and focusing on a fiducial mark on a specimen slide. A plurality of pixels are identified as candidate pixels. A pixel is identified as a candidate pixel based on a number of empty pixels in an area defined by boundary lines extending from the pixel, and one or more dimensions, such as the perimeter, of the defined area. The candidate pixel enclosing the largest area is selected from the group or set of candidate pixels, and the coordinates of that pixel are considered to be the coordinates of the corner of the fiducial mark. The methods can be performed using different gray values that define dark or fiducial pixels and light or empty pixels. Differences between the results at different gray values can be used as focus scores for automatic focusing on the fiducial mark.
Abouammoh, Marwan A. (2015). "Advances in the treatment of central serous chorioretinopathy". Saudi Journal of Ophthalmology. ... also known as central serous chorioretinopathy, CSC). This should be borne in mind when treating patients with optic neuritis. ... "Corticosteroids and central serous chorioretinopathy". Ophthalmology. 109 (10): 1834-7. doi:10.1016/S0161-6420(02)01117-X. PMID ... Clinical and experimental evidence indicates that corticosteroids can cause permanent eye damage by inducing central serous ...
Haimovici R, Gragoudas ES, Duker JS, Sjaarda RN, Eliott D (October 1997). "Central serous chorioretinopathy associated with ... Nasal corticosteroids may be associated with central serous retinopathy. Beclometasone is mainly a glucocorticoid. ...
Central serous chorioretinopathy: CSCR Causes round or oval scotoma. Macular pucker: Macular pucker also known as an epiretinal ... All the charts measures 10 cm × 10 cm in size, which can be used to measure central 20 degree visual field when kept at a ... Chart 5 has central white dot and horizontal white lines on black background 5mm apart, which allow detecting metamorphopsia. ... Chart 6 is similar to chart 5, but lines and central dot is in black on white background. The lines near to fixation points are ...
Karim SP, Adelman RA (2013). "Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy". ... Verteporfin is also used off-label for the treatment of central serous retinopathy. Verteporfin is given intravenously, 15 ...
"Verteporfin (Visudyne®) photo-dynamic therapy in the management of chronic central serous chorioretinopathy" (PDF). Northern ...
In about 25% of all patients with a chronic central serous chorioretinopathy, a proliferation of blood vessels from the choroid ... The best known representative of the pachychoroid disease spectrum, central serous chorioretinopathy, is the fourth most common ... central serous chorioretinopathy (CCS) develops. In this stage, patients often have blurred vision and report a reduction in ... "Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy". Ophthalmology. 126 (4): 576- ...
Chorioretinopathy: In Central serous chorioretinopathy, using ICGA multifocal areas of choroidal hyperpermiability can be ... ICGA allows better visualization of lesions in serpiginous chorioretinopathy, punctate inner chorioretinopathy, acute zonal ... It is also useful in diagnosing and classifying CNV associated to serous pigment epithelial detachments in Nonexudative macular ... In birdshoot chorioretinopathy, lesions appear as symmetrical round or oval hypoflourescent spots. ...
Haimovici R, Gragoudas ES, Duker JS, Sjaarda RN, Eliott D (October 1997). "Central serous chorioretinopathy associated with ...
Central Serous Chorioretinopathy (CSCR) which can produce micropsia predominantly affects persons between the ages of 20 and 50 ... or central serous retinopathy), by changes in the brain (such as from traumatic brain injury, epilepsy, migraines, prescription ... For this test, patients are asked to look at a grid, and distortions or blank spots in the patient's central field of vision ... CSCR is a disease in which a serous detachment of the neurosensory retina occurs over an area of leakage from the ...
... also known as central serous chorioretinopathy, CSC).[6] A variety of steroid medications, from anti-allergy nasal sprays ( ... "Advances in the treatment of central serous chorioretinopathy". Saudi Journal of Ophthalmology. 29 (4): 278-286. doi:10.1016/j. ... "Corticosteroids and central serous chorioretinopathy". Ophthalmology. 109 (10): 1834-7. doi:10.1016/S0161-6420(02)01117-X. PMID ... Clinical and experimental evidence indicates that corticosteroids can cause permanent eye damage by inducing central serous ...
Fluids may also accumulate in a choroid spaces under the retina, causing central serous retinopathy or chorioretinopathy and ... Central nervous system dysfunction and extensive skeletal anomalies suggest a role for Phosphatidylinositol 3,5-bisphosphate, ...
... may refer to: Complexe sportif Claude-Robillard Central serous chorioretinopathy This disambiguation page lists articles ...
... hyperpermeable vessels leading to central serous chorioretinopathy among other conditions. Simultaneous stereo fundus photos ... The main structures that can be visualized on a fundus photo are the central and peripheral retina, optic disc and macula. ... which then passes through a central aperture to form an annulus, before passing through the camera objective lens and through ...
Central core disease Central diabetes insipidus Central nervous system protozoal infections Central serous chorioretinopathy ... Central type neurofibromatosis Centromeric instability immunodeficiency syndrome Centronuclear myopathy Centrotemporal epilepsy ... g Congenital cardiovascular disorder Congenital cardiovascular malformations Congenital cardiovascular shunt Congenital central ... Chorea Choreoacanthocytosis amyotrophic Choreoathetosis familial paroxysmal Choriocarcinoma Chorioretinitis Chorioretinopathy ...
... a printed security code on payment cards such as credits and debit cards Central serous chorioretinopathy, an eye disease ...
... (CSC or CSCR), also known as Central serous retinopathy (CSR), is an eye disease that causes ... Central serous chorioretinopathy as a complication of epitheliopathy under treatment with glucocorticoids]" [Central serous ... Recently, central serous chorioretinopathy has been understood to be part of the pachychoroid spectrum. In pachychoroid ... "Retinal Physician - Central Serous Chorioretinopathy and Topical NSAIDs". Retinal Physician. Archived from the original on 30 ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... Symmetrical reticular opacities form in the superficial central cornea of both eyes at about 4-5 years of age in Reis-Bücklers ... Lattice dystrophy starts as fine branching linear opacities in Bowman's layer in the central area and spreads to the preiphery ... Historically, an accumulation of small gray variable shaped punctate opacities of variable shape in the central deep corneal ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... and the meninges of the central nervous system.[2][3][4][5][6] ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular ... and multiple exudative bullous serous retinal detachments.[2][5][6] ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... and sight in the central visual field.[4] The progression of disease symptoms occurs in a symmetrical manner, with both the ... eventually extending into the central visual field as tunnel vision increases. Visual acuity and color vision can become ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... The central image represents forward gaze, and each image around it represents gaze in that direction (for example, in the ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... The head may be tilted in such a way that one of the floaters drifts towards the central axis of the eye. In the sharpened ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... The central retinal vein is the venous equivalent of the central retinal artery and, like that blood vessel, it can suffer from ... Central Retinal Vein Occlusion at eMedicine *^ a b Braithwaite T, Nanji AA, Lindsley K, Greenberg PB (2014). "Anti-vascular ... Since the central retinal artery and vein are the sole source of blood supply and drainage for the retina, such occlusion can ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... "Central nervous system tuberculosis". African Health Sciences. 11 (1): 116-27. PMC 3092316. PMID 21572867 ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... PMD lacks apical corneal scarring, Rizutti's phenomenon, Munson's sign, and the central corneal thickness is usually normal.[2] ... The center of the cornea shows normal thickness, with an intact central epithelium, but the inferior cornea exhibits a ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
Central serous retinopathy. *Macular edema. *Epiretinal membrane (Macular pucker). *Vitelliform macular dystrophy ... Birdshot chorioretinopathy. Other. *Glaucoma / Ocular hypertension / Primary juvenile glaucoma. *Floater. *Leber's hereditary ...
central serous chorioretinopathy (CSC or CSCR), also known as Central serous retinopathy (CSR), is an eye disease that causes ... Central serous chorioretinopathy as a complication of epitheliopathy under treatment with glucocorticoids]" [Central serous ... Recently, central serous chorioretinopathy has been understood to be part of the pachychoroid spectrum. In pachychoroid ... "Retinal Physician - Central Serous Chorioretinopathy and Topical NSAIDs". Retinal Physician. Archived from the original on 30 ...
... is a disease in which a serous detachment of the neurosensory retina occurs over an area of leakage from the choriocapillaris ... encoded search term (Central Serous Chorioretinopathy) and Central Serous Chorioretinopathy What to Read Next on Medscape. ... Central serous chorioretinopathy (CSCR) is a disease in which a serous detachment of the neurosensory retina occurs over an ... Central Serous Chorioretinopathy. Updated: Jun 18, 2019 * Author: Kean Theng Oh, MD; Chief Editor: Andrew A Dahl, MD, FACS more ...
... Eliana Costanzo,1,2 Salomon Yves Cohen,1 ... To analyze optical coherence tomography angiography (OCTA) findings in eyes with central serous chorioretinopathy (CSC) and to ... which were frequently associated with serous retinal detachment, presence of dark spots (7/33 eyes) which were frequently ...
Background To evaluate the retinal and choroidal alterations in steroid-associated central serous chorioretinopathy (CSC) in ... Central serous chorioretinopathy (CSC) is a common chorioretinal disorder, characterized by serous retinal detachment in the ... Central serous chorioretinopathy: A seasonal variation? Br J Ophthalmol. 1984;68(10):724-6.CrossRefPubMedPubMedCentralGoogle ... Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol. 1984;68(11):815-20.CrossRefPubMedPubMedCentralGoogle ...
All patients had central serous cho... Arm/Group Description All patients had central serous chorioretinopathy and were treated ... Eplerenone for Central Serous Chorioretinopathy. The safety and scientific validity of this study is the responsibility of the ... Patients with central serous chorioretinopathy were recruited in the ophthalmology clinic at Tufts Medical Center in Boston, MA ... Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (Lond). 2010 Dec;24(12):1743-56. doi: 10.1038/ ...
... natural history and pathophysiology of central serous chorioretinopathy (CSCR). The ... including idiopathic central serous choroidopathy, central serous retinopathy and diffuse retinal pigment epitheliopathy. ... natural history and pathophysiology of central serous chorioretinopathy (CSCR).. The authors conducted a literature search for ... Clinically, CSCR can present acutely as serous neurosensory detachment that often resolves spontaneously within six months, as ...
Eplerenone for Central Serous Chorioretinopathy. The safety and scientific validity of this study is the responsibility of the ... Central Serous Chorioretinopathy. Eplerenone. Optical Coherence Tomography. Enhanced Depth Imaging. Subretinal Fluid. ... Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (Lond). 2010 Dec;24(12):1743-56. doi: 10.1038/ ... Finasteride for chronic central serous chorioretinopathy. Retina. 2011 Apr;31(4):766-71. doi: 10.1097/IAE.0b013e3181f04a35. ...
Most cases of central serous retinopathy clear up in one or two months without any treatment. During this time, your ...
... is a disease in which a serous detachment of the neurosensory retina occurs over an area of leakage from the choriocapillaris ... encoded search term (Central Serous Chorioretinopathy) and Central Serous Chorioretinopathy What to Read Next on Medscape ... Central Serous Chorioretinopathy Treatment & Management. Updated: Jun 18, 2019 * Author: Kean Theng Oh, MD; Chief Editor: ... Central Serous Chorioretinopathy in African Americans at Wilmer Eye Institute. J Natl Med Assoc. 2018 Jun. 110 (3):297-302. [ ...
... Cheng Li,1 Xiaoxiao Feng,1 Xin ... To evaluate the retinal vessel oxygen saturation in central serous chorioretinopathy (CSC) cases among the Chinese. Methods. ...
Central serous chorioretinopathy (CSC) is a relatively frequent eye disease in younger patients. It is characterized by serous ... Treatment Trial for Acute Central Serous Chorioretinopathy. The safety and scientific validity of this study is the ... The purpose of this study is to evaluate the effect of micropulse laser (MPL) on acute central serous chorioretinopathy ... Trial to Evaluate the Effects of 577nm Micropulse Laser vs Traditional Laser Therapy on Acute Central Serous Chorioretinopathy ...
... in central serous chorioretinopathy (CSC). Prospective, randomized, double-masked, non-inferiority, 12-week clinical trial. ... Central serous chorioretinopathy (CSC) is a relatively common early-onset disease characterized by serous detachment of the ... Liew G, Quin G, Gillies M, Fraser-Bell S. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin ... Gupta B, Elagouz M, McHugh D, Chong V, Sivaprasad S. Micropulse diode laser photocoagulation for central serous chorio- ...
To report the anatomic and functional outcome of intravitreal dobesilate to treat recurrent central serous chorioretinopathy ( ... Central serous chorioretinopathy (CSC) is a well-characterized self-limiting disorder leading to serous neurosensory elevation ... Spide RF,Campeas L,Haas A,Yannuzzi LA,Fisher YL,Guyer DR,Slakter JS,Sorenson JA,Orlock DA,Central serous chorioretinopathy in ... Central Serous Chorioretinopathy / drug therapy*, pathology. Ethamsylate / administration & dosage. Fluorescein Angiography. ...
The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy. The safety and scientific validity of this ... Central Serous Chorioretinopathy. Retinal Diseases. Eye Diseases. Bevacizumab. Endothelial Growth Factors. Antineoplastic ... The pathophysiology of central serous chorioretinopathy remains controversial. traditional treatment is laser photocoagulation ... Intraocular Concentrations of Growth Factors and Cytokines in Chronic Central Serous Chorioretinopathy And the Effect of ...
Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy ... Central serous chorioretinopathy (CSC) has been known since it was first described by Von Graefe and termed "idiopathic ... disorder leading to serous neurosensory elevation of the central macula. The acute form of the disease is associated with focal ...
Other common complaints include micropsia, metamorphopsia, hyperopic (most common) or myopic shift, central scotoma, and ... cause a serous detachment of the neurosensory retina. Recurrence occurs in about 31% patients with CSCR,[3] though the ... CSCR typically occurs in males in their 20s to 50s who exhibit acute or sub-acute central vision loss or distortion. ... Central serous chorioretinopathy (CSCR) is the fourth most common retinopathy after age-related macular degeneration, diabetic ...
To evaluate the effectiveness of low-dose aspirin for the treatment of central serous chorioretinopathy (CSCR).Patients and ... central serous chorioretinopathy, aspirin, plasminogen activator inhibitor 1, macula ... Low-dose aspirin as treatment for central serous chorioretinopathy Antonio Caccavale1, Filippo Romanazzi1, Manuela Imparato1, ... Purpose: To evaluate the effectiveness of low-dose aspirin for the treatment of central serous chorioretinopathy (CSCR).. ...
Central serous chorioretinopathy (CSC) is a common choroidal disorder which often affects the vision of young adults. Although ... The mean central choroidal thickness of secondary CSC was 294.8 ± 95.0 μm, which was significantly thinner than that of ... Central choroidal thickness was measured by optical coherent tomography. Choroidal vessel dilation and choroidal vascular ...
Clinical characteristics of bilateral central serous chorioretinopathy Nobuhiro Terao; Tetsuya Yamagishi; Yuto Katoh; Shigeru ... Clinical characteristics of bilateral central serous chorioretinopathy You will receive an email whenever this article is ... Purpose : To elucidate the clinical characteristics of patients with bilateral central serous chorioretinopathy (CSC). ... Clinical characteristics of bilateral central serous chorioretinopathy. Invest. Ophthalmol. Vis. Sci. 2016;57(12):4954. ...
To describe a spectrum of severe chronic central serous chorioretinopathy (cCSC) cases and their response to photodynamic ... Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy Danial Mohabati,1,2 ... Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy. ... Purpose: To describe a spectrum of severe chronic central serous chorioretinopathy (cCSC) cases and their response to ...
Josianne C. E. M. ten Berge; Elon H. C. van Dijk; Marco W. J. Schreurs; Jacolien Vermeer; Camiel J. F. Boon; Aniki Rothova + Author Information ...
Central serous chorioretinopathy (CSCR) is characterized by serous retinal detachment and sometimes retinal pigment epithelial ... Correlation between fundus autofluorescence and central visual function in chronic central serous chorioretinopathy. Am J ... Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye. 2010;24(12):1743-56. doi: 10.1038/eye.2010.130. ... Color vision defects after central serous chorioretinopathy. Retina. 2000;20(6):633-7.CrossRefPubMedGoogle Scholar ...
Central serous chorioretinopathy in women Priyanka Sanghi; Marta Zola; Deepthy Menon; Namritha Patrao; Jayashree Ramu; Philip ... Central serous chorioretinopathy in women You will receive an email whenever this article is corrected, updated, or cited in ... Purpose : Central serous chorioretinopathy (CSC) is predominantly seen in young and middle-aged males. Women do not respond to ... Central serous chorioretinopathy in women. Invest. Ophthalmol. Vis. Sci. 2016;57(12):2157. ...
Aim To report the discordance in central serous chorioretinopathy (CSCR) classification among practising retina specialists. ...
A retrospective chart review of newly diagnosed cases of central serous chorioretinopathy revealed 11 patients, seven men and ... After resolution of the central serous chorioretinopathy, patients were left with subtle alterations in the retinal pigment ... Firstly, the presence of subretinal exudation does not necessarily rule out the diagnosis of central serous chorioretinopathy. ... Secondly, pathophysiological theories of central serous chorioretinopathy must explain how the plaques are deposited behind the ...
... the part of the retina responsible for central vision, and can cause distorted or blurry vision. ... Central Serous Chorioretinopathy affects the macula, the part of the retina responsible for central vision. This disorder is ... Central serous chorioretinopathy can lead to a "serous detachment" or blister beneath the retina, which causes distorted or ... Central serous chorioretinopathy is more common among men between 25 and 45, although younger or older men or women can also ...
Short-Term Efficacy of Intravitreal Dobesilate in Central Serous Chorioretinopathy.. Authors: Cuevas, Pedro; Outeiriño, Luis A. ... To report the anatomic and functional outcome of intravitreal dobesilate to treat recurrent central serous chorioretinopathy ( ...
Also known as: Central Serous Chorioretinopathy / Central Serous Retinopathy (CSR) / Central Serous Retinopathy / Serous ... Central Serous Chorioretinopathy (CSC) Completed Phase 1 / 2 Trials for Omeprazole (DB00338). Back to Central Serous ... DBCOND0050251 (Central Serous Chorioretinopathy (CSC)). Completed. 1 / 2. clinicaltrials.gov Identifier. Title. Purpose. Drugs ... Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR). Treatment. *Amoxicillin ( ...
Omeprazole Completed Phase 1 / 2 Trials for Central Serous Chorioretinopathy (CSC) Treatment. Back to Omeprazole ...
Central serous chorioretinopathy (CSCR) is a condition that affects central visual function. It can produce blurred and/or ... Incident and Recurrent Cases of Central Serous Chorioretinopathy, Active Component, U.S. Armed Forces, 2001-2018 A patient ... Central serous chorioretinopathy (CSCR) is caused by fluid under the retina in the subretinal space. Fluid accumulation causes ... Central serous chorioretinopathy in U.S. Air Force aviators: a review. Aviat Space Environ Med. 1988;59(12):1170-1175. ...
  • central serous chorioretinopathy (CSC or CSCR), also known as Central serous retinopathy (CSR), is an eye disease that causes visual impairment, often temporary, usually in one eye. (wikipedia.org)
  • Central serous chorioretinopathy (CSCR) is a disease in which a serous detachment of the neurosensory retina occurs over an area of leakage from the choriocapillaris through the retinal pigment epithelium (RPE). (medscape.com)
  • This article reviews the epidemiology, risk factors, clinical presentation, natural history and pathophysiology of central serous chorioretinopathy (CSCR). (aao.org)
  • The authors conducted a literature search for CSCR, as well as other names that have been used to describe the condition, including idiopathic central serous choroidopathy, central serous retinopathy and diffuse retinal pigment epitheliopathy. (aao.org)
  • Clinically, CSCR can present acutely as serous neurosensory detachment that often resolves spontaneously within six months, as recurrent episodes often occurring within the first year, or chronically with distinctive retinal pigment epithelium changes and persistent shallow retinal detachments. (aao.org)
  • The goal of the study is to examine the short-term effects and safety of a systemic anti-aldosterone medication, eplerenone, in a small group of patients with central serous chorioretinopathy (CSCR). (clinicaltrials.gov)
  • Furthermore, an evaluation of 230 consecutive patients with central serous chorioretinopathy (CSCR) found that use of psychopharmacologic agents (eg, anxiolytics, antidepressants) was a risk factor for CSCR. (medscape.com)
  • Use of corticosteroids in the treatment of CSCR should be avoided because it may result in exacerbation of serous detachments already present. (medscape.com)
  • Laser photocoagulation should be considered under the following circumstances: (1) persistence of a serous retinal detachment for more than 4 months, (2) recurrence in an eye with visual deficit from previous CSCR, (3) presence of visual deficits in opposite eye from previous episodes of CSCR, and (4) occupational or other patient need requiring prompt recovery of vision. (medscape.com)
  • Central serous chorioretinopathy (CSCR) is the fourth most common retinopathy after age-related macular degeneration, diabetic retinopathy and branch retinal vein occlusion. (aao.org)
  • [1] CSCR typically occurs in males in their 20s to 50s who exhibit acute or sub-acute central vision loss or distortion. (aao.org)
  • [2] No underlying pathophysiologic mechanisms have been proven, but CSCR is thought to occur due to hyper-permeable choroidal capillaries, which, in association with retinal pigment dysfunction, cause a serous detachment of the neurosensory retina. (aao.org)
  • To evaluate the effectiveness of low-dose aspirin for the treatment of central serous chorioretinopathy (CSCR). (dovepress.com)
  • Aim To report the discordance in central serous chorioretinopathy (CSCR) classification among practising retina specialists. (bmj.com)
  • Central serous chorioretinopathy (CSCR) is a condition that affects central visual function. (health.mil)
  • CSCR can affect critical visual performance by degrading central visual acuity. (health.mil)
  • Central serous chorioretinopathy (CSCR) is caused by fluid under the retina in the subretinal space. (health.mil)
  • Purpose: To investigate choriocapillaris flow signal void distribution on optical coherence tomography (OCT) angiography in central serous chorioretinopathy (CSCR) and its correlation to choroidal vessel morphology. (octnews.org)
  • Central serous chorioretinopathy (CSCR) is a problem that affects the macula (central portion of the retina). (hontos.gr)
  • CSCR is often a straightforward clinical diagnosis when it presents as a typical serous neurosensory retinal detachment in a middle-aged male. (hontos.gr)
  • Another atypical variant of CSCR usually is found in healthy middle-aged men and presents with multiple PEDs and multiple bullous serous neurosensory detachments that demonstrate shifting fluid. (hontos.gr)
  • Based on recent exogenous steroid use, macular pigmentary changes, subretinal fluid, serous pigment epithelial detachments, and a thick choroid in both eyes, the patient was diagnosed with central serous chorioretinopathy (CSCR). (eyerounds.org)
  • CSCR is a relatively common, idiopathic retinopathy that causes fluctuating vision loss, often affecting central vision. (eyerounds.org)
  • We report a case of central serous chorioretinopathy (CSCR) after caesarean section of a 37-year-old Caucasian woman. (medcraveonline.com)
  • Central serous chorioretinopathy (CSCR) is a serous detachment of the neurosensory retina, respectively retinal pigment epithelium (RPE) caused by a focal breakdown of the outer blood-retina barrier resulting in an accumulation of fluid between the photoreceptor outer segments and the RPE [1]. (medcraveonline.com)
  • 3University Eye Clinic, Foundation IRCCS San Matteo Hospital, Pavia, Italy Abstract: Despite numerous studies describing predominantly its demography and clinical course, many aspects of central serous chorioretinopathy (CSCR) remain unclear. (spotidoc.com)
  • www.dovepress.com Dovepress DOI: 10.2147/OPTH.S17182 Central serous chorioretinopathy (CSCR) has been described by various names for nearly a century and a half.1-3 Despite numerous studies on this disease over the years, many aspects of CSCR remain unclear. (spotidoc.com)
  • Central Serous Chorioretinopathy (CSCR) is an accumulation of subretinal fluid with detachment of the neurosensory retina mainly found in young caucasian males. (anncaserep.com)
  • Central Serous Chorioretinopathy (CSCR) is defined by the accumulation of subretinal fluid with detachment of the neurosensory retina. (anncaserep.com)
  • Fluorescein angiography (FA) and indocyanine green angiography (ICGA) are considered the gold-standard tests for the assessment of vascular diseases of the retina and choroid, in particular primary or secondary macular neovascularization (MNV), diabetic retinopathy, retinal vascular occlusions, macular telangiectasia, and central serous chorioretinopathy (CSCR). (healio.com)
  • Acute Vogt-Koyanagi-Harada (VKH) disease and acute central serous chorioretinopathy (CSCR) are two common disorders with serous retinal detachment caused by dysfunction of choroid. (biomedcentral.com)
  • Central serous chorioretinopathy (CSCR) is a common disease characterized by serous detachment of the neurosensory retina and/or the retinal pigment epithelium (RPE) that often involves the macula. (biomedcentral.com)
  • To investigate the molecular composition of subretinal fluid (SRF) in central serous chorioretinopathy (CSCR) and rhegmatogenous retinal detachment (RRD) using proteomics and metabolomics. (arvojournals.org)
  • Central serous chorioretinopathy (CSCR) is characterized by serous detachments of the neurosensory retina, frequently affecting the macula, focal pigment epithelial detachments, increased choroidal thickness and choroidal vascular hyperpermeability. (arvojournals.org)
  • Central serous chorioretinopathy (CSCR) belongs to pachychoroid spectrum of diseases, and the pathogenesis is still not fully understood. (egyptretinaj.com)
  • We used search terms such as "central serous retinopathy," "central serous chorioretinopathy," "CSCR," "management," and "treatment" and also the keywords of each type of treatment on PubMed and Medline to retrieve articles for this systematic review. (egyptretinaj.com)
  • To evaluate the beneficial effects of rifampin for the treatment of central serous chorioretinopathy (CSCR). (binajournal.org)
  • The condition was named Idiopathic central serous chorioretinopathy by Gass et al in 1967. (aao.org)
  • OCTA showed 3 main anomalies at the choriocapillaris: the presence of dark areas (19/33 eyes) which were frequently associated with serous retinal detachment, presence of dark spots (7/33 eyes) which were frequently associated with retinal pigment epithelium detachment, and presence of abnormal vessels (12/33 eyes) which were frequently, but not systematically, associated with choroidal neovascularization, as confirmed by multimodal imaging. (hindawi.com)
  • To evaluate the retinal and choroidal alterations in steroid-associated central serous chorioretinopathy (CSC) in comparison to idiopathic CSC. (springer.com)
  • Central serous chorioretinopathy (CSC) is a common choroidal disorder which often affects the vision of young adults. (ovid.com)
  • Central choroidal thickness was measured by optical coherent tomography. (ovid.com)
  • The mean central choroidal thickness of secondary CSC was 294.8 ± 95.0 μm, which was significantly thinner than that of idiopathic CSC (409.4 ± 124.7 μm, P = 0.00064). (ovid.com)
  • Purpose To evaluate the three-dimensional choroidal vascularity index (CVI) in the eyes with treatment-naïve acute central serous chorioretinopathy (CSC) using swept-source optical coherence tomography (SS OCT). Methods In this prospective cross-sectional study, OCT and OCT angiography covered an area of 12 × 12 mm centered on the fovea. (octnews.org)
  • Central serous chorioretinopathy, polypoidal choroidal vasculopathy, pachychoroid pigment epitheliopathy, or all of the above? (cybersight.org)
  • Central serous chorioretinopathy results from the leaking of choroidal fluid into the subretinal area. (naturalcurefor.com)
  • To investigate potential genetic prognostic factors associated with spontaneous resolution of serous retinal detachment (SRD) and development of choroidal neovascularization (CNV) in central serous chorioretinopathy (CSC). (cdc.gov)
  • The central choroidal thickness (CCT), the cross sectional subfoveal choroidal area, the hyporeflective and hyperreflective areas of the inner, outer, and whole choroid were determined at the baseline, and at 1, 3, and 12 months after the hPDT. (tokushima-u.ac.jp)
  • Central serous chorioretinopathy (CSC) is characterized by serous detachment of the neurosensory retina associated with choroidal vascular hyperpermeability [ 2 , 3 ]. (ekjo.org)
  • We sought to elucidate the influence of acetazolamide on choroidal structure changes during the treatment of central serous chorioretinopathy (CSC). (bvsalud.org)
  • Since then it has been reported under a variety of names such as idiopathic flat detachment of the macula by Walsh et al, central angiospastic retinopathy by Gifford et al, and central serous retinopathy by Straatsma et al. (aao.org)
  • Differentiation between recently resolved optic neuritis and central serous retinopathy. (springermedizin.de)
  • Central Serous Chorioretinopathy (CSC or CSR - short for Central Serous Retinopathy) occurs in young adults who complain of central blurring of vision. (asiaretina.com)
  • Who is at risk of Central Serous Chorioretinopathy or Central Serous Retinopathy? (asiaretina.com)
  • What are the caues of Central Serous Chorioretinopathy/Central Serous Retinopathy? (asiaretina.com)
  • Causes of Central Serous Retinopathy are not clearly understood, although there are certain risk factors identified that contribute to the likelihood of developing this condition. (asiaretina.com)
  • A link has been found between Central Serous Retinopathy and persons with a "Type A" personality and/or persons undergoing emotional duress as a risk factor. (asiaretina.com)
  • Central serous retinopathy (CSR), also known as central serous choroidopathy (CSC), is an eye condition that develops due to an accumulation of fluid under the retina. (joshiretina.com)
  • While central serous retinopathy usually affects one eye at a time both eyes can be affected at the same time. (joshiretina.com)
  • More men, in their mid 30's to 50's, are affected with central serous retinopathy than women. (joshiretina.com)
  • The cause of central serous retinopathy is unknown. (joshiretina.com)
  • More than half of the patients who develop central serous retinopathy have a recurrence of the condition. (joshiretina.com)
  • Clinical and experimental evidence indicates that corticosteroids can cause permanent eye damage by inducing central serous retinopathy (CSR, also known as central serous chorioretinopathy, CSC). (wikipedia.org)
  • traditional treatment is laser photocoagulation or photodynamic therapy.Recently Bevacizumab (Avastin, Genetech),an antibody to vascular endothelial growth factor (VEGF),has known antipermeability properties and therefore may theoretically reverse the changes seen in central serous chorioretinopathy. (clinicaltrials.gov)
  • To describe a spectrum of severe chronic central serous chorioretinopathy (cCSC) cases and their response to photodynamic therapy (PDT). (dovepress.com)
  • To evaluate the long-term results of indocyanine green angiography(ICGA)-guided verteporfin (Visudyne®, Novartis, Basel, Switzerland) photodynamic therapy (PDT) with half-fluence rate in the treatment of acute symptomatic central serous chorioretinopathy (CSC). (springermedizin.de)
  • Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study. (springermedizin.de)
  • Ozkaya A, Alkin Z, Ozveren M, Yazici AT, Taskapili M. The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case-control study. (springermedizin.de)
  • Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. (springermedizin.de)
  • Purpose: To report the use of photodynamic therapy with verteporfin as a treatment for patients with focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy (CSC). (elsevier.com)
  • To determine the structural changes in the choroid after half-dose photodynamic therapy (hPDT) in eyes with chronic central serous chorioretinopathy (CSC). (tokushima-u.ac.jp)
  • To study the macular sensitivity after half-dose verteporfin photodynamic therapy in patients with resolved central serous chorioretinopathy using the automated static perimeter. (altmetric.com)
  • Eyes with resolved central serous chorioretinopathy after half-dose verteporfin photodynamic therapy had lower macular sensitivity than normal fellow eyes. (altmetric.com)
  • Purpose: To assess the visual and anatomic outcomes of central serous chorioretinopathy (CSC) after verteporfin photodynamic therapy (PDT).Design: Retrospective case series.Participants: Patients with CSC who underwent PDT.Methods: Members of the Macula Society were surveyed to retrospectively collect data on PDT treatment for CSC. (linkoph.com)
  • Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser. (ox.ac.uk)
  • PURPOSE: To compare the outcome between high-density subthreshold micropulse laser (HSML) treatment and half-dose photodynamic therapy (PDT) in chronic central serous chorioretinopathy (cCSC) patients, subdivided based on either focal or diffuse leakage on fluorescein angiography (FA). (ox.ac.uk)
  • The purpose of this study is to evaluate the effect of micropulse laser (MPL) on acute central serous chorioretinopathy compared with the traditional laser coagulation. (clinicaltrials.gov)
  • The study is a prospective randomized controlled trial about 577nm micropulse laser versus traditional laser coagulation therapy on acute central serous chorioretinopathy. (clinicaltrials.gov)
  • Although the majority of cases of acute central serous chorioretinopathy are self-limited, resolving spontaneously after a number of weeks, the recurrence rate is estimated to be 20-50 %, and some cases will be chronic, lasting 6 months or longer. (springermedizin.de)
  • The purpose of this work was to estimate the efficiency of H. pylori infection eradication in treatment of patients with acute central serous chorioretinopathy. (springermedizin.de)
  • Ninety-three patients with acute central serous chorioretinopathy participated in this study. (springermedizin.de)
  • Helicobacter pylori eradication is effective in the treatment of H. pylori -positive patients with acute central serous chorioretinopathy. (springermedizin.de)
  • Acute central serous chorioretinopathy lasts for a short time and is self-limited (it resolves spontaneously), reason why the visual prognosis is good. (icrcat.com)
  • To investigate genetic associations in white patients with acute central serous chorioretinopathy (aCSC) and to assess genetic differences between aCSC and chronic CSC (cCSC). (cdc.gov)
  • abstract = "PURPOSE: To investigate genetic associations in white patients with acute central serous chorioretinopathy (aCSC) and to assess genetic differences between aCSC and chronic CSC (cCSC).METHODS: A total of 135 aCSC patients, 272 cCSC patients, and 1,385 control individuals were included. (eyehospital.nl)
  • Mattingly, JJ, Amram, AL & El-Annan, J 2018, ' Low-dose rifampin as maintenance therapy in chronic central serous chorioretinopathy ', Canadian Journal of Ophthalmology . (utmb.edu)
  • When the disorder is active it is characterized by leakage of fluid under the retina that has a propensity to accumulate under the central macula. (wikipedia.org)
  • Central serous chorioretinopathy (CSC) has been known since it was first described by Von Graefe and termed "idiopathic detachment of the macula" in 1866, is a well-characterized disorder leading to serous neurosensory elevation of the central macula. (centerwatch.com)
  • Central Serous Chorioretinopathy affects the macula, the part of the retina responsible for central vision. (vrmny.com)
  • In many cases the leak is very near the central macula, where photocoagulation would leave a blind spot. (checkorphan.org)
  • Transpupillary thermotherapy has been suggested as a lower-risk alternative to laser photocoagulation in cases where the leak is in the central macula. (checkorphan.org)
  • There is a small serous PED in the right macula with adjacent RPE changes, but no fluid. (illinoisretina.com)
  • Central Serous Chorioretinopathy (CSC or CSR) is a disorder which causes the accumulation of fluid under the macula in an otherwise healthy eye. (nycretina.com)
  • This accumulation of fluid under the macula causes blurring of the central vision in the affected eye. (nycretina.com)
  • A major interest in a well-known and not uncommon disorder of the macula is central serous chorioretinopathy. (maculafoundation.org)
  • A patient with central serous chorioretinopathy with a detachment of the macula beneath the fovea with fibrin in that space. (maculafoundation.org)
  • The disorder is characterized by leakage of fluid in the central macula usually with a "blister" appearance (Fig 1), which results in blurred or distorted vision (metamorphopsia). (californiaretina.com)
  • Vision loss, especially if the serous pocket is situated well within the macula, is sometimes described as well. (asiaretina.com)
  • When the serous detachment is at the edge or outside the macula, symptoms may not be as apparent to the patient. (asiaretina.com)
  • Serous detachments and fluid leakage that develop outside of the macula may go undetected for extended periods of time, and may have done more damage to important parts of the eye or retina such as the retinal pigment epithelium - where damage may result in atrophy of the photoreceptor cells in the retina. (asiaretina.com)
  • Funduscopy of the right eye revealed a serous elevation of the macula (Figure 1). (medcraveonline.com)
  • A serous detachment of the macula with subretinal fluid and RPE-bumps is seen. (medcraveonline.com)
  • Central serous chorioretinopathy (CSR) is a relatively common condition that affects the macula (the part of the retina responsible for central vision). (rvscny.com)
  • Central serous chorioretinopathy is a condition of the eye wherein the central macula leaks fluid from the choriocapillaris, resulting in blurry vision. (naturalcurefor.com)
  • Some patients can opt for laser photocoagulation, although the process may sometimes result in a blind spot when the central macula is too close to the leak. (naturalcurefor.com)
  • Patients with central serous chorioretinopathy were recruited in the ophthalmology clinic at Tufts Medical Center in Boston, MA between April 2013 and April 2017. (clinicaltrials.gov)
  • A retrospective chart review of newly diagnosed cases of central serous chorioretinopathy revealed 11 patients, seven men and four non-pregnant women, who had plaques of subretinal exudate, which presumably were fibrin. (bmj.com)
  • Most cases of central serous chorioretinopathy resolve without treatment after several weeks or months. (retinaeyecenter.com)
  • Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A, Manea M (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. (springermedizin.de)
  • Serous retinal detachment disappeared 4 months after delivery with visual acuity of 1.2 in either eye. (elsevier.com)
  • At presentation, the visual acuity of the right eye was 8/20 and funduscopy revealed a central serous detachment of the retina. (medcraveonline.com)
  • Four days after the caesarean section the patient experienced a sudden decrease of visual acuity combined with a central scotoma and metamorphopsia in her right eye. (medcraveonline.com)
  • At presentation, best-corrected visual acuity of the right eye was 8/20 with metamorphopsia, a central scotoma in Amsler's grid and blurred vision. (medcraveonline.com)
  • Central serous chorioretinopathy (CSC) is a common chorioretinal disorder, characterized by serous retinal detachment in the posterior pole, often associated with serous pigment epithelial detachments (PED) and retinal pigment epithelium (RPE) atrophy. (springer.com)
  • This edema or leakage puts pressure on the RPE, causing it o blister up into focal or multifocal elevations known as serous detachments of the pigment epithelium. (vrmny.com)
  • So the face of Sattler's layer, especially with a thickened choroid, can be very helpful in differentiating these diseases from other causes of serous retinal detachments. (cybersight.org)
  • One or multiple serous smal l pigment epithelial detachments. (amretina.com)
  • In the right eye, the central macular thickness was 274 microns and there were several small serous pigment epithelial detachments nasal to the fovea without fluid. (eyerounds.org)
  • In the left eye, the central macular thickness 527 microns and there was subretinal fluid beneath the fovea with adjacent serous pigment epithelial detachments. (eyerounds.org)
  • The central macular thickness in the left eye was 302 microns (previously 527 microns) and there was improved subfoveal fluid as well as smaller serous pigment epithelial detachments compared to previous. (eyerounds.org)
  • Stratus optical coherence tomography (OCT) (Carl Zeiss Meditec, Inc., Dublin, California, US) shows many changes appearing in retinal layers, especially in the photoreceptor layer in the area of the serous detachments in CSC. (touchophthalmology.com)
  • Fluorescein angiography may be employed in the diagnosis of central serous chorioretinopathy. (retinaeyecenter.com)
  • Central serous chorioretinopathy (CSC) is a relatively common early-onset disease characterized by serous detachment of the neural retina with dysfunction of the choroid and retinal pigment epithelium (RPE). (nature.com)
  • While patients with central serous chorioretinopathy tend to be far-sighted and have an unusually thick choroid, they usually have no other eye diseases. (vrmny.com)
  • Loss of the tight junctions permits fluid from the choroid to pass through the pigment epithelial layer and produce a serous detachment of the neuro retina. (optos.com)
  • Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. (springermedizin.de)
  • To compare the efficacy and safety of subthreshold micropulse laser (SML) with threshold conventional laser (TCL) in central serous chorioretinopathy (CSC). (nature.com)
  • Subretinal exudative deposits in central serous chorioretinopathy. (bmj.com)
  • After resolution of the central serous chorioretinopathy, patients were left with subtle alterations in the retinal pigment epithelium in the areas of the subretinal plaque. (bmj.com)
  • Firstly, the presence of subretinal exudation does not necessarily rule out the diagnosis of central serous chorioretinopathy. (bmj.com)
  • All patients were diagnosed with central serous chorioretinopathy. (clinicaltrials.gov)
  • Laser treatment also may be considered in patients with recurrent episodes of serous detachment with a leak located more than 300 µm from the center of the fovea. (medscape.com)
  • Central serous chorioretinopathy (CSC) is a relatively frequent eye disease in younger patients. (clinicaltrials.gov)
  • To elucidate the clinical characteristics of patients with bilateral central serous chorioretinopathy (CSC). (arvojournals.org)
  • Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy. (springermedizin.de)
  • Fluorescein angiogram in patients with this condition shows leakage within the area of serous retinal detachment(s), most classically fitting one of two patterns - the "expansile dot" or "smokestack. (illinoisretina.com)
  • The evidence of Helicobacter pylori infection appears more often in patients with central serous chorioretinopathy. (springermedizin.de)
  • Fok AC, Chan PP, Lam DS, Lai TY (2011) Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy. (springermedizin.de)
  • PURPOSE: To describe the clinical findings and long-term outcome of patients with chronic central serous chorioretinopathy (cCSC). (ox.ac.uk)
  • Though it can occur in adults of all ages, young and middle-aged adults are form the largest age group for Central Serous Chorioretinopathy patients. (asiaretina.com)
  • At later stages, patients may experience loss of central vision. (asiaretina.com)
  • When investigated, roughly about half the patients suffering from Central Serous Chorioretinopathy have at least one relative with traces of this condition upon examination. (asiaretina.com)
  • Patients complain about a decrease of vision, metamorphopsia, central scotoma and micropsia. (medcraveonline.com)
  • Patient characteristics of untreated chronic central serous chorioretinopathy patients with focal versus diffuse leakage. (ox.ac.uk)
  • This was a retrospective interventional study of 29 eyes of 29 patients who underwent hPDT for chronic CSC with serous retinal detachment (SRD) and were followed for ≥3 months. (tokushima-u.ac.jp)
  • PurposeTo evaluate the safety and efficacy of finasteride treatment in patients with central serous chorioretinopathy (CSC).MethodsRetrospective review of 29 eyes of 23 patients who were treated with finasteride for CSC. (elsevier.com)
  • Prospective consecutive case study of 24 patients with resolved central serous chorioretinopathy was performed. (altmetric.com)
  • PURPOSE: To investigate factors associated with good response to intravitreal bevacizumab (IVB) in central serous chorioretinopathy (CSC) patients. (yonsei.ac.kr)
  • To compare retrobulbar blood flow in patients with central serous chorioretinopathy (CSC) and healthy subjects using color Doppler ultrasonography. (yyu.edu.tr)
  • To analyze optical coherence tomography angiography (OCTA) findings in eyes with central serous chorioretinopathy (CSC) and to compare them with those obtained with multimodal imaging. (hindawi.com)
  • Multifocal Central Serous Chorioretinopathy is a rare variant of central serous chorioretinopathy, but is common in pathogenesis to its more common sister condition. (illinoisretina.com)
  • Otsuka S, Ohba N, Nakao K (2002) A long-term follow-up study of severe variant of central serous chorioretinopathy. (springermedizin.de)
  • What tests are used in diagnosis of Central Serous Chorioretinopathy? (asiaretina.com)
  • The pathophysiology of central serous chorioretinopathy remains controversial. (clinicaltrials.gov)
  • It is characterized by serous detachment of the neurosensory retina with or without serous detachment of the retinal pigment epithelium (RPE), which can cause vision drop, image distortion, loss of color and contrast vision. (clinicaltrials.gov)
  • Clinical diagnosis of b-CSC was based on the presence of serous retinal detachment (SRD) in at least 1 eye and past or present SRD in the fellow eye. (arvojournals.org)
  • Purpose: The purpose of the study is to investigate the demographic characteristics and clinical findings of central serous chorioretinopathy (CSC). (northwestern.edu)
  • To compare clinical, angiographic, and optical coherence tomographic characteristics between eyes with acute Vogt-Koyanagi-Harada (VKH) disease and eyes with acute bilateral central serous chorioretinopathy (CSC), and to demonstrate distinguishing features between the two diseases in confusing cases. (ekjo.org)
  • Central serous chorioretinopathy (CSC) is a disease characterised by idiopathic serous neurosensory retinal detachment secondary to leakage from retinal pigment epithelium (RPE). (touchophthalmology.com)
  • Eplerenone, a generic medication, is a potassium sparing diuretic, which is FDA approved to treat heart failure as well as high blood pressure, but is not FDA approved for treatment of central serous chorioretinopathy. (clinicaltrials.gov)
  • Central serous chorioretinopathy: update on pathophysiology and treatment. (illinoisretina.com)
  • To evaluate the safety and efficacy of selective retina therapy (SRT) with real-time feedback-controlled dosimetry (RFD) in the treatment of chronic central serous chorioretinopathy (CSC). (semanticscholar.org)
  • We also review the diagnostic testing required and potential treatment modalities for central serous chorioretinopathy. (cybersight.org)
  • Unfortunately, there is no known treatment for central serous chorioretinopathy. (naturalcurefor.com)
  • Marwan A. Abouammoh , Advances in the treatment of central serous chorioretinopathy, Saudi J. Ophthalmol. (who.int)
  • Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy. (unil.ch)
  • One of the challenges of detecting central serous chorioretinopathy is differentiating between the two kinds of leakage. (vrmny.com)
  • Mean central foveal thickness was 107.1 ± 21.3 μm in the focal group and 106.2 ± 27.3 μm in the diffuse group (p = 0.818). (ox.ac.uk)
  • abstract = "Purpose: To report central serous chorioretinopathy (CSR) that became manifest in the late stage of normal pregnancy. (elsevier.com)
  • Typical symptoms include objects appearing smaller than normal (micropsia), straight lines appearing wavy (metamorphopsia), or partial loss or distortion of a portion of the central visual field. (health.mil)
  • What Are The Signs And Symptoms Of Central Serous Chorioretinopathy? (nycretina.com)
  • Early symptoms of CSR include a dim and blurred spot in the central vision. (rvscny.com)
  • RA: Fundus photograph of central serous chorioretinopathy in 37-year old woman 4 days after caesarean section. (medcraveonline.com)
  • Fundus photo (A), OCT (B) and retinal thickness map (C) of right and left eyes at presentation showing extensive serous retinal detachment in the right eye and a smaller detachment in the left eye. (anncaserep.com)
  • Note when high IOP spotted a corrected IOP documented after central corneal thickness measurement. (amretina.com)
  • 10 The authors showed that outer nuclear layer (ONL) thickness (the measurement between the internal limiting membrane [ILM] and the ELM) in the central fovea was approximately 75 μm in CSC, and was statistically significant shorter than the average thickness of 135 μm in healthy eyes. (touchophthalmology.com)
  • The primary efficacy measure will be percent change in central subfield thickness as measured by OCT at 8 weeks. (rush.edu)
  • Other common complaints include micropsia, metamorphopsia, hyperopic (most common) or myopic shift, central scotoma, and reduced contrast sensitivity and color saturation. (aao.org)
  • Four days after an uneventful delivery of twins, the patient noticed blurry vision, metamorphopsia and central scotoma of her right eye. (medcraveonline.com)
  • Central serous chorioretinopathy (CSC) is a well-characterized self-limiting disorder leading to serous neurosensory elevation of the retina. (biomedsearch.com)
  • Objective: Central serous chorioretinopathy (CSC) is a chorioretinal disorder characterized by an accumulation of serous fluid under the retina. (trialbulletin.com)
  • Central serous chorioretinopathy is often suspected when an individual presents with 'blisters' of fluid under the retina or RPE (Figure 1). (retinaeyecenter.com)
  • Optical coherence tomography (OCT) is commonly used to obtain a high-resolution image of the retina, RPE, and fluid accumulations from central serous chorioretinopathy (Figure 5, 6). (retinaeyecenter.com)
  • PURPOSE: To report the anatomic and functional outcome of intravitreal dobesilate to treat recurrent central serous chorioretinopathy (CSC). (biomedsearch.com)
  • The disease was first recognized by Albrecht von Graefe in 1866 and was named central recurrent retinitis. (aao.org)
  • PURPOSE: To describe the characteristics and potential differences between focal and diffuse phenotypes of untreated chronic central serous chorioretinopathy (cCSC). (ox.ac.uk)
  • This is how central serous chorioretinopathy occurs. (icrcat.com)
  • Central serous chorioretinopathy occurs in men aged 20-55 years. (naturalcurefor.com)